Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Nkarta Inc (NASDAQ: NKTX)

 
NKTX Technical Analysis
5
As on 25th Apr 2025 NKTX STOCK Price closed @ 2.11 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 6.81 & Strong Sell for SHORT-TERM with Stoploss of 4.55 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NKTXSTOCK Price

Open 2.15 Change Price %
High 2.15 1 Day -0.09 -4.09
Low 2.04 1 Week 0.40 23.39
Close 2.11 1 Month 0.39 22.67
Volume 452793 1 Year -0.22 -9.44
52 Week High 15.71 | 52 Week Low 1.37
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
GNLN 0.01 -50.00%
AGMH 0.05 25.00%
OMEX 1.51 77.65%
NVDA 111.01 4.30%
WW 0.40 166.67%
TSLA 284.95 9.80%
INTC 20.05 -6.70%
OPEN 0.76 -2.56%
LMDX 0.02 0.00%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
ZWZZT 25.00 2375.25%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
WW 0.40 166.67%
WINVR 0.12 140.00%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
TFFP 0.06 -62.50%
ATMH 0.04 -60.00%
MILEW 0.06 -53.85%
LOTZW 0.01 -50.00%
 
 
NKTX
Daily Charts		 NKTX
Intraday Charts		 Whats New @
Bazaartrend		 NKTX
Free Analysis
 
NKTX Important Levels Intraday
RESISTANCE2.32
RESISTANCE2.25
RESISTANCE2.21
RESISTANCE2.17
SUPPORT2.05
SUPPORT2.01
SUPPORT1.97
SUPPORT1.90
 
NKTX Forecast April 2025
Share
4th UP Forecast19.49
3rd UP Forecast13.92
2nd UP Forecast10.47
1st UP Forecast7.03
1st DOWN Forecast-2.81
2nd DOWN Forecast-6.25
3rd DOWN Forecast-9.7
4th DOWN Forecast-15.27
 
NKTX Weekly Forecast
4th UP Forecast3.56
3rd UP Forecast3.09
2nd UP Forecast2.81
1st UP Forecast2.52
1st DOWN Forecast1.70
2nd DOWN Forecast1.41
3rd DOWN Forecast1.13
4th DOWN Forecast0.66
 
NKTX Forecast2025
4th UP Forecast30.88
3rd UP Forecast21.65
2nd UP Forecast15.95
1st UP Forecast10.25
1st DOWN Forecast-6.03
2nd DOWN Forecast-11.73
3rd DOWN Forecast-17.43
4th DOWN Forecast-26.66
 
 
NKTX Other Details
Segment EQ
Market Capital 539668224.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NKTX Address
NKTX
 
NKTX Latest News
 
Your Comments and Response on Nkarta Inc
 
NKTX Business Profile
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Its two co-lead product candidates are NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes; and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells. The company was incorporated in 2015 and is based in South San Francisco, California. Address: 6000 Shoreline Court, South San Francisco, CA, United States, 94080
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service